Candice Davison Shares a Review on Kell and Kx Blood Group Systems
Candice Davison, Project Research Scientist – Genomics Transfusion Array at Australian Red Cross Lifeblood, shared on LinkedIn:
”Excited to share a recent collaboration with my mentor Dr. Gregory A. Denomme—our review on the Kell (ISBT 006) and Kx (ISBT 019) blood group systems is now published in Immunohematology!
Since 2015, these systems have expanded significantly, with new antigens and alleles registered by ISBT.
Advances in molecular diagnostics are reshaping how we resolve serologic challenges and predict fetal blood type in alloimmunised pregnancies—critical for preventing HDFN.
Anti-K remains a key clinical concern, and emerging technologies like single-cell sequencing and gene editing are opening new doors to understanding red cell biology and immunogenicity.
Davison CL, Denomme GA. Kell and Kx blood group systems: an update. Immunohematology. 2025 Oct 31;41(3):90–99. doi: 10.2478/immunohematology-2025-014
Grateful for the opportunity to learn and contribute alongside a mentor who continues to shape the field!
Your guidance, insight, and generosity Greg, have made this collaboration deeply meaningful.”
Read the abstract here.
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis